8 min listen
Hertzel Gerstein on dulaglutide, erectile dysfunction, and T2D
FromThe Lancet Diabetes & Endocrinology in conversation with
Hertzel Gerstein on dulaglutide, erectile dysfunction, and T2D
FromThe Lancet Diabetes & Endocrinology in conversation with
ratings:
Length:
24 minutes
Released:
Jul 9, 2021
Format:
Podcast episode
Description
Hertzel Gerstein talks with The Lancet Diabetes & Endocrinology about how dulaglutide might reduce the incidence of moderate or severe erectile dysfunction in men with type 2 diabetes.Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00115-7/fulltext
Released:
Jul 9, 2021
Format:
Podcast episode
Titles in the series (48)
The Lancet Diabetes & Endocrinology: February 26, 2013 by The Lancet Diabetes & Endocrinology in conversation with